Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1053

3.
5.
9.

The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.

Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.

Eur J Gynaecol Oncol. 1998;19(3):203-8.

PMID:
9641214
10.
12.

Managing atypical squamous cells of undetermined significance in Papanicolaou smears.

Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.

J Reprod Med. 2001 Sep;46(9):799-805.

PMID:
11584480
13.
14.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
15.
17.

Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?

Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.

J Fam Pract. 1998 Feb;46(2):125-34.

PMID:
9487318
19.

Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management.

Lee SJ, Jung KL, Lee JW, Song SY, Kim BG, Lee JH, Park CS, Bae DS.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):664-9.

PMID:
16681744
20.

[Application of high-risk human papillomavirus testing in women with abnormal cytology].

Ou H, Bian ML, Zhang XY, Chen QY, Li M, Chen Y, Liu J.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):608-11. Chinese.

Supplemental Content

Support Center